PARA-AMINOBENZOIC ACID IN LEUKEMIA

Abstract
Sodium para-aminobenzoate caused a decrease in the leukocyte count in myelogenous leukemia, but there was little objective clinical improvement. The leukocyte count increased when the drug was discontinued.